FantasticSearch

Scroll to: TopResults

Explore European Union Legislation by Asking a Legal Question

assisted-checkbox

filter-instruction-1
positive-filters
negative-filters
act-filter tabs-all

parameters-title

query

assisted-checkbox:

result-title

total 2

Regulation (EC) No 851/2004 of the European Parliament and of the Council of 21 april 2004 establishing a European Centre for disease prevention and control

article  5a

CELEX:  02004R0851-20221226

Prevention of communicable diseases
1. The Centre shall support Member States in strengthening their communicable disease prevention and control capacities, and in improving and facilitating the data collection process with interoperable sharing of data.
2. In close collaboration with Member States, the European Medicines Agency (EMA) and other relevant Union bodies and agencies, as well as with international organisations, the Centre shall develop a framework for the prevention of communicable diseases and related special health issues, including socio-economic risk factors, vaccine preventable diseases, antimicrobial resistance, health promotion, health education, health literacy and behaviour change.
3. The Centre may provide guidelines for the creation of communicable disease prevention and control programmes. It shall evaluate and monitor such programmes in order to provide evidence for science-based recommendations for the purposes of coordinating, strengthening and improving such programmes at national, cross-border interregional and Union level, and, where appropriate, at international level.
Regulation (EC) No 851/2004 of the European Parliament and of the Council of 21 april 2004 establishing a European Centre for disease prevention and control

article  5a

CELEX:  02004R0851-20221226

4. The Centre shall monitor the level of vaccination coverage in respect of major communicable diseases in each Member State, taking into account the specificities of national and regional vaccination schedules.
5. The Centre shall coordinate independent, post-marketing monitoring studies of the effectiveness and safety of vaccines, and shall collect new information, use the relevant data collected by competent bodies, or both. That work shall be conducted jointly with EMA and in particular through a new vaccine monitoring platform.